Figure 4From: Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panelsIllustration of PSA identification in clinical samples by mass spectrometry-based proteomic analysis. (A) The molecular structure of PSA with three typical tryptic peptides used for identification by sequences (colored regions). Mass spectra generated from molecular forms of PSA by both (B) high resolving FT full and (C) corresponding MS/MS fragmentation scans of those tryptic peptides highlighted with the same colors.Back to article page